Outcomes of Endoscopic Submucosal Dissection for Treatment of Superficial Pharyngeal Cancers : Systematic Review and Meta-Analysis
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
BACKGROUND AND AIMS: Studies evaluating the role of endoscopic submucosal dissection (ESD) in the management of superficial pharyngeal cancers have reported promising results. This meta-analysis evaluates the efficacy and safety of ESD in the management of superficial pharyngeal cancers.
METHODS: We reviewed several databases from inception to September 03, 2020, to identify studies evaluating the efficacy and safety of ESD in the management of superficial pharyngeal cancers. Our outcomes of interest were en bloc resection rate, complete resection rate, adverse events, and rates of local recurrence. Pooled rates with 95% confidence intervals (CI) for all outcomes were calculated using random-effect model. Heterogeneity was assessed by I2 statistic. We assessed publication bias by using funnel plots and Egger's test. We conducted meta-regression analysis to explore heterogeneity in analyses.
RESULTS: Ten studies were included in analyses. All studies were from Asia. Pooled rates (95% CI) for en bloc resection and complete resection were 94% (87%, 97%) and 72% (62%, 80%), respectively. The pooled rates (95% CI) for adverse events and local recurrence were 10% (5%, 17%) and 1.9% (0.9%, 4%), respectively. Most of the analyses were limited by substantial heterogeneity. On meta-regression analysis, the heterogeneity was explained by size of tumor and histology. Funnel plots and Egger's test showed no evidence of publication bias.
CONCLUSIONS: This meta-analysis including studies from Asian countries demonstrated that ESD is an efficacious and safe option in the management of superficial pharyngeal cancers. More studies and studies from Western countries are needed to further validate these findings.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:67 |
|---|---|
| Enthalten in: |
Digestive diseases and sciences - 67(2022), 8 vom: 09. Aug., Seite 3518-3528 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kamal, Faisal [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 19.07.2022 Date Revised 18.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10620-021-07225-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330474987 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330474987 | ||
| 003 | DE-627 | ||
| 005 | 20231225211349.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10620-021-07225-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330474987 | ||
| 035 | |a (NLM)34505257 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kamal, Faisal |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of Endoscopic Submucosal Dissection for Treatment of Superficial Pharyngeal Cancers |b Systematic Review and Meta-Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.07.2022 | ||
| 500 | |a Date Revised 18.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a BACKGROUND AND AIMS: Studies evaluating the role of endoscopic submucosal dissection (ESD) in the management of superficial pharyngeal cancers have reported promising results. This meta-analysis evaluates the efficacy and safety of ESD in the management of superficial pharyngeal cancers | ||
| 520 | |a METHODS: We reviewed several databases from inception to September 03, 2020, to identify studies evaluating the efficacy and safety of ESD in the management of superficial pharyngeal cancers. Our outcomes of interest were en bloc resection rate, complete resection rate, adverse events, and rates of local recurrence. Pooled rates with 95% confidence intervals (CI) for all outcomes were calculated using random-effect model. Heterogeneity was assessed by I2 statistic. We assessed publication bias by using funnel plots and Egger's test. We conducted meta-regression analysis to explore heterogeneity in analyses | ||
| 520 | |a RESULTS: Ten studies were included in analyses. All studies were from Asia. Pooled rates (95% CI) for en bloc resection and complete resection were 94% (87%, 97%) and 72% (62%, 80%), respectively. The pooled rates (95% CI) for adverse events and local recurrence were 10% (5%, 17%) and 1.9% (0.9%, 4%), respectively. Most of the analyses were limited by substantial heterogeneity. On meta-regression analysis, the heterogeneity was explained by size of tumor and histology. Funnel plots and Egger's test showed no evidence of publication bias | ||
| 520 | |a CONCLUSIONS: This meta-analysis including studies from Asian countries demonstrated that ESD is an efficacious and safe option in the management of superficial pharyngeal cancers. More studies and studies from Western countries are needed to further validate these findings | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a Endoscopic dissection | |
| 650 | 4 | |a Endoscopic resection | |
| 650 | 4 | |a Endoscopic submucosal resection | |
| 650 | 4 | |a Pharyngeal carcinoma | |
| 650 | 4 | |a Pharyngeal neoplasm | |
| 650 | 4 | |a Pharyngeal squamous cell carcinoma | |
| 700 | 1 | |a Khan, Muhammad Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Lee-Smith, Wade |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Sachit |e verfasserin |4 aut | |
| 700 | 1 | |a Imam, Zaid |e verfasserin |4 aut | |
| 700 | 1 | |a Jowhar, Dawit |e verfasserin |4 aut | |
| 700 | 1 | |a Petryna, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Esswein, Julia |e verfasserin |4 aut | |
| 700 | 1 | |a Acharya, Ashu |e verfasserin |4 aut | |
| 700 | 1 | |a Aziz, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Farooq, Umer |e verfasserin |4 aut | |
| 700 | 1 | |a Zafar, Usman |e verfasserin |4 aut | |
| 700 | 1 | |a Mcdonough, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Adler, Douglas G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Digestive diseases and sciences |d 1989 |g 67(2022), 8 vom: 09. Aug., Seite 3518-3528 |w (DE-627)NLM000356492 |x 1573-2568 |7 nnns |
| 773 | 1 | 8 | |g volume:67 |g year:2022 |g number:8 |g day:09 |g month:08 |g pages:3518-3528 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10620-021-07225-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 67 |j 2022 |e 8 |b 09 |c 08 |h 3518-3528 | ||